Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Convergence through Complexity: How to Cure Brain Disease; Orion Bionetworks 2nd Annual Conference
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Chronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
Multiple sclerosis review.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
[Information processing speed and influential factors in multiple sclerosis].
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Betaseron (Interferon Beta-1b) for SC Injection
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »